KLINiSOL

About KLINiSOL

KLINiSOL is a boutique contract research organization built for Investigator-Initiated Trials. We help academic researchers and physician-investigators take studies from concept to completion within FDA and EMA regulatory frameworks — providing the infrastructure, regulatory expertise, and compliance support that IIT sponsors often lack, without the overhead of a large CRO. Our approach is grounded in a decade of hands-on clinical trial operations under real regulatory scrutiny: audit-ready documentation, full ICH-GCP compliance, and inspection readiness from day one. At our core is ILO, an AI-powered, 21 CFR Part 11-compliant and GAMP 5-validated clinical trial operating system. By consolidating the fragmented tools most trials run on into a single platform, ILO helps studies move faster, smarter, and more compliantly. Built with the rigor investigator-initiated research demands, ILO scales to trials of any size and any sponsor — pharma, CRO, ARO, or investigator network.